response

Copado Hosts India’s Flagship DevOps Conference in Response to Overwhelming Demand

CHICAGO, Sept. 4, 2025 /PRNewswire/ -- Copado, the leader in AI-powered DevOps for business applications, today announced the first ever CopadoCon…

3 months ago

Strategic Optimism Amid Domestic Stability: Small Businesses Recalibrate Plans in Response to Evolving Demand and Profitability Trends – ASSOCHAM Dun & Bradstreet Small Business Confidence Index

MUMBAI, India, Aug. 26, 2025 /PRNewswire/ -- ASSOCHAM along with Dun & Bradstreet, a leading global provider of business decisioning data…

3 months ago

Bybit Unveils 1H 2025 Report: A Masterclass in Crisis Response, AI-Driven Innovation, and Market Leadership

DUBAI, UAE, Aug. 25, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume,  has published its 1H 2025 Half-Year…

3 months ago

Vehere Announces v1.8.1 Delivering Sharper Detection, Faster Response, and Smarter Workflows for Security Analysts

SAN FRANCISCO, July 17, 2025 /PRNewswire/ -- Vehere, a leading provider of AI-powered Cyber Network Intelligence, has officially rolled out…

5 months ago

Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)

July 11, 2025 16:30 ET  | Source: Ultragenyx Pharmaceutical Inc. Complete Response Letter (CRL) cited specific chemistry, manufacturing and controls…

5 months ago

Fidelis Security Integrates With Palo Alto Networks To Deliver Enhanced Network Detection and Response in Zero Trust Environments

RIVERSIDE, Calif., July 8, 2025 /PRNewswire/ -- Fidelis Security, a leader in proactive cyber defense, today announced an integration with…

5 months ago

New Glassnode Report: How Bybit’s Response to the Lazarus Hack Became Crypto’s Defining Stress Test

DUBAI, UAE, July 1, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, has been featured in a…

5 months ago

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)

Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial show investigational treatment with epcoritamab in combination with…

6 months ago

Sangfor Receives Frost & Sullivan’s 2025 APAC Customer Value Leadership Recognition in the Extended Detection and Response Market

Frost & Sullivan applauds Sangfor for delivering advanced, AI-powered cybersecurity with exceptional customer value across the APAC region. SAN ANTONIO,…

6 months ago